Drug Screening Market Size and Analysis by 2023 to 2029
Accurate information and innovative corporate analysis are provided in the Drug Screening Market research report to assist businesses of all sizes in making wise decisions. The worldwide market outlook for emerging and developed markets is also included in the research on Drug Screening. The report also looks into the areas and countries that are anticipated to experience the fastest growth rates over the course of the projection period.
The research report on Drug Screening also offers insights into the various geographic areas contributing to market expansion. The competitive environment is also a part of it, and leading businesses are using tactics to disclose partnerships and collaborations to support market expansion.
The global drug screening market is expected to grow at 17% CAGR from 2022 to 2029. It is expected to reach above USD 6.07 billion by 2029 from USD 5.21 billion in 2020.
Download FREE Sample Report @ https://exactitudeconsultancy.com/reports/8956/drug-screening-market#request-a-sample
The report provides a comprehensive analysis of company profiles listed below: LabCorp, Quest Diagnostics, Abbott Laboratories, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, MPD Inc., Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, and Siemens Healthineers, and others.
Key Segments
Global Drug Screening Market by Product and Services, 2020-2029, (USD Million)
Consumables
Urine Testing Devices
Analytical
Breathalyzer
Chromatography
Immunoassay
Global Drug Screening Market by Sample Type, 2020-2029, (USD Million)
Urine, Breath
Oral Fluid/Saliva
Hair
Other Samples (Blood & Sweat)
Global Drug Screening Market by End User Industry, 2020-2029, (USD Million)
Workplace
Laboratories
Criminal Justice
Hospitals